Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rhythm Pharmaceuticals (RYTM) Return on Assets: 2021-2025

Historic Return on Assets for Rhythm Pharmaceuticals (RYTM) over the last 5 years, with Sep 2025 value amounting to -0.44%.

  • Rhythm Pharmaceuticals' Return on Assets rose 26.00% to -0.44% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.44%, marking a year-over-year increase of 26.00%. This contributed to the annual value of -0.72% for FY2024, which is 20.00% down from last year.
  • Latest data reveals that Rhythm Pharmaceuticals reported Return on Assets of -0.44% as of Q3 2025, which was up 9.30% from -0.48% recorded in Q2 2025.
  • Rhythm Pharmaceuticals' Return on Assets' 5-year high stood at -0.14% during Q2 2021, with a 5-year trough of -0.93% in Q1 2024.
  • For the 3-year period, Rhythm Pharmaceuticals' Return on Assets averaged around -0.60%, with its median value being -0.56% (2023).
  • In the last 5 years, Rhythm Pharmaceuticals' Return on Assets tumbled by 51bps in 2022 and then spiked by 49bps in 2025.
  • Quarterly analysis of 5 years shows Rhythm Pharmaceuticals' Return on Assets stood at -0.23% in 2021, then decreased by 24bps to -0.47% in 2022, then decreased by 7bps to -0.54% in 2023, then decreased by 15bps to -0.69% in 2024, then rose by 26bps to -0.44% in 2025.
  • Its last three reported values are -0.44% in Q3 2025, -0.48% for Q2 2025, and -0.43% during Q1 2025.